Interferons (IFNs) are important cytokines that regulate immune responses through the activation of hundreds of genes, including interferon-induced transmembrane proteins (IFITMs). This evolutionarily conserved protein family includes five functionally active homologs in humans. Despite the high sequence homology, IFITMs vary in expression, subcellular localization and function. The initially described adhesive and antiproliferative or pro-oncogenic functions of IFITM proteins were diluted by the discovery of their antiviral properties. The large set of viruses that is inhibited by these proteins is constantly expanding, as are the possible mechanisms of action. In addition to their beneficial antiviral effects, IFITM proteins are often upregulated in a broad spectrum of cancers. IFITM proteins have been linked to most hallmarks of cancer, including tumor cell proliferation, therapeutic resistance, angiogenesis, invasion, and metastasis. Recent studies have described the involvement of IFITM proteins in antitumor immunity. This review summarizes various levels of IFITM protein regulation and the physiological and pathological functions of these proteins, with an emphasis on tumorigenesis and antitumor immunity.

Department of Experimental Biology Faculty of Science Masaryk University Brno Czechia

Institute of Genetics and Molecular Medicine University of Edinburgh Edinburgh United Kingdom

Research Centre for Applied Molecular Oncology Masaryk Memorial Cancer Institute Brno Czechia

Zobrazit více v PubMed

Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: A complex web of host defenses. Annu Rev Immunol (2014) 32:513–45. doi: 10.1146/annurev-immunol-032713-120231 PubMed DOI PMC

Schoggins JW. Interferon-stimulated genes: What do they all do? Annu Rev Virol (2019) 6:567–84. doi: 10.1146/annurev-virology-092818-015756 PubMed DOI

Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM. Molecular analysis of a human interferon-inducible gene family. Eur J Biochem (1991) 199:417–23. doi: 10.1111/j.1432-1033.1991.tb16139.x PubMed DOI

Zhang Z, Liu J, Li M, Yang H, Zhang C. Evolutionary dynamics of the interferon-induced transmembrane gene family in vertebrates. PLoS One (2012) 7:e49265. doi: 10.1371/journal.pone.0049265 PubMed DOI PMC

Takahashi S, Doss C, Levy S, Levy R. TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the leu-13 antigen. J Immunol (1990) 145:2207–13. PubMed

Kita K, Sugaya S, Zhai L, Wu YP, Wano C, Chigira S, et al. . Involvement of LEU13 in interferon-induced refractoriness of human RSa cells to cell killing by X rays. Radiat Res (2003) 160:302–8. doi: 10.1667/RR3039 PubMed DOI

Narayana SK, Helbig KJ, McCartney EM, Eyre NS, Bull RA, Eltahla A, et al. . The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis c virus entry. J Biol Chem (2015) 290:25946–59. doi: 10.1074/jbc.M115.657346 PubMed DOI PMC

Zhao X, Li J, Winkler CA, An P, Guo J-T. IFITM genes, variants, and their roles in the control and pathogenesis of viral infections. Front Microbiol (2019) 9:3228. doi: 10.3389/fmicb.2018.03228 PubMed DOI PMC

Li K, Markosyan RM, Zheng Y-M, Golfetto O, Bungart B, Li M, et al. . IFITM proteins restrict viral membrane hemifusion. PLoS Pathog (2013) 9:e1003124. doi: 10.1371/journal.ppat.1003124 PubMed DOI PMC

Rahman K, Coomer CA, Majdoul S, Ding SY, Padilla-Parra S, Compton AA. Homology-guided identification of a conserved motif linking the antiviral functions of IFITM3 to its oligomeric state. eLife (2020) 9:e58537. doi: 10.7554/eLife.58537 PubMed DOI PMC

Majdoul S, Compton AA. Lessons in self-defence: inhibition of virus entry by intrinsic immunity. Nat Rev Immunol (2022) 22:339–52. doi: 10.1038/s41577-021-00626-8 PubMed DOI PMC

Yánez DC, Sahni H, Ross S, Solanki A, Lau C, Papaioannou E, et al. . IFITM proteins drive type 2 T helper cell differentiation and exacerbate allergic airway inflammation. Eur J Immunol (2019) 49:66–78. doi: 10.1002/eji.201847692 PubMed DOI PMC

Lee J, Geng H, Chen Z, Park E, Klemm L, Bailey CC, et al. . Ifitm3 (CD225) mediates CD19-dependent survival and proliferation during normal b cell development and in ph+ ALL. Blood (2013) 122:2505–5. doi: 10.1182/blood.V122.21.2505.2505 DOI

Wang Z, Zhang A, Wan Y, Liu X, Qiu C, Xi X, et al. . Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci (2014) 111:769–74. doi: 10.1073/pnas.1321748111 PubMed DOI PMC

Ogony J, Choi HJ, Lui A, Cristofanilli M, Lewis-Wambi J. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner. Breast Cancer Res (2016) 18:25. doi: 10.1186/s13058-016-0683-7 PubMed DOI PMC

Andreu P, Colnot S, Godard C, Laurent-Puig P, Lamarque D, Kahn A, et al. . Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res (2006) 66:1949–55. doi: 10.1158/0008-5472.CAN-05-2731 PubMed DOI

Yan J, Jiang Y, Lu J, Wu J, Zhang M. Inhibiting of proliferation, migration, and invasion in lung cancer induced by silencing interferon-induced transmembrane protein 1 (IFITM1). BioMed Res Int (2019) 2019:e9085435. doi: 10.1155/2019/9085435 PubMed DOI PMC

Wu X, Thi VLD, Huang Y, Billerbeck E, Saha D, Hoffmann H-H, et al. . Intrinsic immunity shapes viral resistance of stem cells. Cell (2018) 172:423–438.e25. doi: 10.1016/j.cell.2017.11.018 PubMed DOI PMC

Popson SA, Ziegler ME, Chen X, Holderfield MT, Shaaban CI, Fong AH, et al. . Interferon-induced transmembrane protein 1 regulates endothelial lumen formation during angiogenesis. Arterioscler Thromb Vasc Biol (2014) 34:1011–9. doi: 10.1161/ATVBAHA.114.303352 PubMed DOI PMC

Weichselbaum RR, Ishwaran H, Yoon T, Nuyten DSA, Baker SW, Khodarev N, et al. . An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U.S.A. (2008) 105:18490–5. doi: 10.1073/pnas.0809242105 PubMed DOI PMC

Lee J, Robinson ME, Ma N, Artadji D, Ahmed MA, Xiao G, et al. . IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in b cells. Nature (2020) 588:491–7. doi: 10.1038/s41586-020-2884-6 PubMed DOI PMC

Chawla-Sarkar M, Lindner DJ, Liu Y-F, Williams BR, Sen GC, Silverman RH, et al. . Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis Int J Program Cell Death (2003) 8:237–49. doi: 10.1023/a:1023668705040 PubMed DOI

Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell (1984) 38:745–55. doi: 10.1016/0092-8674(84)90270-8 PubMed DOI

Johnson MC, Sangrador-Vegas A, Smith TJ, Cairns MT. Cloning and characterization of two genes encoding rainbow trout homologues of the IFITM protein family. Vet Immunol Immunopathol (2006) 110:357–62. doi: 10.1016/j.vetimm.2005.12.007 PubMed DOI

Kelly JM, Gilbert CS, Stark GR, Kerr IM. Differential regulation of interferon-induced mRNAs and c-myc mRNA by alpha- and gamma-interferons. Eur J Biochem (1985) 153:367–71. doi: 10.1111/j.1432-1033.1985.tb09312.x PubMed DOI

Kim J, Shin C-G. IFITM proteins inhibit the late step of feline foamy virus replication. Anim Cells Syst (2020) 24:282–8. doi: 10.1080/19768354.2020.1819413 PubMed DOI PMC

Lu Y, Zuo Q, Zhang Y, Wang Y, Li T, Han J. The expression profile of IFITM family gene in rats. Intractable Rare Dis Res (2017) 6:274–80. doi: 10.5582/irdr.2017.01066 PubMed DOI PMC

Reid LE, Brasnett AH, Gilbert CS, Porter ACG, Gewert DR, Stark GR, et al. . A single DNA response element can confer inducibility by both a- and y-interferons. Proc Natl Acad Sci USA (1989) 86:840–4. doi: 10.1073/pnas.86.3.840 PubMed DOI PMC

Lange U, Saitou M, Western P, Surani M. The fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice. BMC Dev Biol (2003) 3:1. doi: 10.1186/1471-213x-3-1 PubMed DOI PMC

Compton AA, Roy N, Porrot F, Billet A, Casartelli N, Yount JS, et al. . Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity. EMBO Rep (2016) 17:1657–71. doi: 10.15252/embr.201642771 PubMed DOI PMC

Hickford D, Frankenberg S, Shaw G, Renfree MB. Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genomics (2012) 13:155. doi: 10.1186/1471-2164-13-155 PubMed DOI PMC

Sällman Almén M, Bringeland N, Fredriksson R, Schiöth HB. The dispanins: A novel gene family of ancient origin that contains 14 human members. PLoS One (2012) 7:e31961. doi: 10.1371/journal.pone.0031961 PubMed DOI PMC

Moffatt P, Gaumond M-H, Salois P, Sellin K, Bessette M-C, Godin É, et al. . Bril: A novel bone-specific modulator of mineralization. J Bone Miner Res (2008) 23:1497–508. doi: 10.1359/jbmr.080412 PubMed DOI

Okuzaki Y, Kidani S, Kaneoka H, Iijima S, Nishijima K. Characterization of chicken interferon-inducible transmembrane protein-10. Biosci Biotechnol Biochem (2017) 81:914–21. doi: 10.1080/09168451.2016.1274639 PubMed DOI

Levy DE, Kessler DS, Pine R, Reich N, Darnell JE. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Amp Dev (1988) 2:383–93. doi: 10.1101/gad.2.4.383 PubMed DOI

Bailey CC, Kondur HR, Huang I-C, Farzan M. Interferon-induced transmembrane protein 3 is a type II transmembrane protein. J Biol Chem (2013) 288:32184–93. doi: 10.1074/jbc.M113.514356 PubMed DOI PMC

Weston S, Czieso S, White IJ, Smith SE, Kellam P, Marsh M. A membrane topology model for human interferon inducible transmembrane protein 1. PLoS One (2014) 9:e104341. doi: 10.1371/journal.pone.0104341 PubMed DOI PMC

Yount JS, Moltedo B, Yang Y-Y, Charron G, Moran TM, López CB, et al. . Palmitoylome profiling reveals s-palmitoylation–dependent antiviral activity of IFITM3. Nat Chem Biol (2010) 6:610–4. doi: 10.1038/nchembio.405 PubMed DOI PMC

Ling S, Zhang C, Wang W, Cai X, Yu L, Wu F, et al. . Combined approaches of EPR and NMR illustrate only one transmembrane helix in the human IFITM3. Sci Rep (2016) 6:24029. doi: 10.1038/srep24029 PubMed DOI PMC

Sun F, Xia Z, Han Y, Gao M, Wang L, Wu Y, et al. . Topology, antiviral functional residues and mechanism of IFITM1. Viruses (2020) 12:295. doi: 10.3390/v12030295 PubMed DOI PMC

Chesarino NM, Compton AA, McMichael TM, Kenney AD, Zhang L, Soewarna V, et al. . IFITM3 requires an amphipathic helix for antiviral activity. EMBO Rep (2017) 18:1740–51. doi: 10.15252/embr.201744100 PubMed DOI PMC

John SP, Chin CR, Perreira JM, Feeley EM, Aker AM, Savidis G, et al. . The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza a virus and dengue virus replication. J Virol (2013) 87:7837–52. doi: 10.1128/JVI.00481-13 PubMed DOI PMC

Muñoz-Moreno R, Cuesta-Geijo MÁ, Martínez-Romero C, Barrado-Gil L, Galindo I, García-Sastre A, et al. . Antiviral role of IFITM proteins in African swine fever virus infection. PLoS One (2016) 11:e0154366. doi: 10.1371/journal.pone.0154366 PubMed DOI PMC

Park H-J, Lee W-Y, Jeong H-Y, Kang H-S, Kim J-B, Song H. Mitochondrial interferon-induced transmembrane protein-1 is a critical regulator of cell death in MPRO cells. Biotechnol Bioprocess Eng (2016) 21:561–6. doi: 10.1007/s12257-016-0253-y DOI

Park SY, Guo X. Adaptor protein complexes and intracellular transport. Biosci Rep (2014) 34:e00123. doi: 10.1042/BSR20140069 PubMed DOI PMC

Chesarino NM, McMichael TM, Hach JC, Yount JS. Phosphorylation of the antiviral protein interferon-inducible transmembrane protein 3 (IFITM3) dually regulates its endocytosis and ubiquitination. J Biol Chem (2014) 289:11986–92. doi: 10.1074/jbc.M114.557694 PubMed DOI PMC

Foster TL, Wilson H, Iyer SS, Coss K, Doores K, Smith S, et al. . Resistance of transmitted founder HIV-1 to IFITM-mediated restriction. Cell Host Microbe (2016) 20:429–42. doi: 10.1016/j.chom.2016.08.006 PubMed DOI PMC

Jia R, Xu F, Qian J, Yao Y, Miao C, Zheng Y-M, et al. . Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol (2014) 16:1080–93. doi: 10.1111/cmi.12262 PubMed DOI PMC

Jia R, Pan Q, Ding S, Rong L, Liu S-L, Geng Y, et al. . The n-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J Virol (2012) 86:13697–707. doi: 10.1128/JVI.01828-12 PubMed DOI PMC

Zhao X, Sehgal M, Hou Z, Cheng J, Shu S, Wu S, et al. . Identification of residues controlling restriction versus enhancing activities of IFITM proteins on entry of human coronaviruses. J Virol (2018) 92:e01535-17. doi: 10.1128/JVI.01535-17 PubMed DOI PMC

Smith RA, Young J, Weis JJ, Weis JH. Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun (2006) 7:113–21. doi: 10.1038/sj.gene.6364278 PubMed DOI

Li K, Jia R, Li M, Zheng Y-M, Miao C, Yao Y, et al. . A sorting signal suppresses IFITM1 restriction of viral entry. J Biol Chem (2015) 290:4248–59. doi: 10.1074/jbc.M114.630780 PubMed DOI PMC

Honda K, Taniguchi T. IRFs: Master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol (2006) 6:644–58. doi: 10.1038/nri1900 PubMed DOI

Kim SH, In Choi H, Choi MR, An GY, Binas B, Jung KH, et al. . Epigenetic regulation of IFITM1 expression in lipopolysaccharide-stimulated human mesenchymal stromal cells. Stem Cell Res Ther (2020) 11:16. doi: 10.1186/s13287-019-1531-3 PubMed DOI PMC

Bailey CC, Huang I-C, Kam C, Farzan M. Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog (2012) 8:e1002909. doi: 10.1371/journal.ppat.1002909 PubMed DOI PMC

Daido H, Zhou MY, Gomez-Sanchez CE. Angiotensin stimulates the expression of interferon-inducible genes in H295R cells. Mol Cell Endocrinol (2001) 176:21–7. doi: 10.1016/s0303-7207(01)00478-6 PubMed DOI

Bedford JG, O’Keeffe M, Reading PC, Wakim LM. Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection. PLoS One (2019) 14:e0210132. doi: 10.1371/journal.pone.0210132 PubMed DOI PMC

Clave E, Carosella ED, Gluckman E, Socié G. Radiation-enhanced expression of interferon-inducible genes in the KG1a primitive hematopoietic cell line. Leukemia (1997) 11:114–9. doi: 10.1038/sj.leu.2400528 PubMed DOI

Smith SE, Gibson MS, Wash RS, Ferrara F, Wright E, Temperton N, et al. . Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses. vitro J Virol (2013) 87:12957–66. doi: 10.1128/JVI.01443-13 PubMed DOI PMC

Sun X, Zeng H, Kumar A, Belser JA, Maines TR, Tumpey TM. Constitutively expressed IFITM3 protein in human endothelial cells poses an early infection block to human influenza viruses. J Virol (2016) 90:11157–67. doi: 10.1128/JVI.01254-16 PubMed DOI PMC

Wakim LM, Gupta N, Mintern JD, Villadangos JA. Enhanced survival of lung tissue-resident memory CD8+ T cells during infection with influenza virus due to selective expression of IFITM3. Nat Immunol (2013) 14:238–45. doi: 10.1038/ni.2525 PubMed DOI

Wu X, Robotham JM, Lee E, Dalton S, Kneteman NM, Gilbert DM, et al. . Productive hepatitis c virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog (2012) 8:e1002617. doi: 10.1371/journal.ppat.1002617 PubMed DOI PMC

Liu X, Chen L, Fan Y, Hong Y, Yang X, Li Y, et al. . IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway. Cell Death Dis (2019) 10:1–16. doi: 10.1038/s41419-019-1750-7 PubMed DOI PMC

Min J, Feng Q, Liao W, Liang Y, Gong C, Li E, et al. . IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling. FEBS Open Bio (2018) 8:1299–311. doi: 10.1002/2211-5463.12479 PubMed DOI PMC

Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, et al. . Genome-wide gene expression differences in crohn’s disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis (2007) 13:807–21. doi: 10.1002/ibd.20110 PubMed DOI

Ye H, Wang X, Wang L, Chu X, Hu X, Sun L, et al. . Full high-throughput sequencing analysis of differences in expression profiles of long noncoding RNAs and their mechanisms of action in systemic lupus erythematosus. Arthritis Res Ther (2019) 21:70. doi: 10.1186/s13075-019-1853-7 PubMed DOI PMC

Provance OK, Lewis-Wambi J. Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer. Breast Cancer Res (2019) 21:59. doi: 10.1186/s13058-019-1140-1 PubMed DOI PMC

Krishnamurthy N, Kurzrock R. Targeting the wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. Cancer Treat Rev (2018) 62:50–60. doi: 10.1016/j.ctrv.2017.11.002 PubMed DOI PMC

Nguyen VHL, Hough R, Bernaudo S, Peng C. Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis. J Ovarian Res (2019) 12:122. doi: 10.1186/s13048-019-0596-z PubMed DOI PMC

Evans PM, Chen X, Zhang W, Liu C. KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin. Mol Cell Biol (2010) 30:372–81. doi: 10.1128/MCB.00063-09 PubMed DOI PMC

Li D, Peng Z, Tang H, Wei P, Kong X, Yan D, et al. . KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis. Clin Cancer Res (2011) 17:3558–68. doi: 10.1158/1078-0432.CCR-10-2729 PubMed DOI PMC

Shi G, Ozog S, Torbett BE, Compton AA. mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3. Proc Natl Acad Sci USA (2018) 115:E10069–78. doi: 10.1073/pnas.1811892115 PubMed DOI PMC

Shi G, Chiramel AI, Majdoul S, Lai KK, Dempsey T, Kenney A, et al. . Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. BioRxiv Prepr Serv Biol (2022). doi: 10.1101/2021.04.15.440067 PubMed DOI PMC

Petrillo C, Thorne LG, Unali G, Schiroli G, Giordano AMS, Piras F, et al. . Cyclosporine h overcomes innate immune restrictions to improve lentiviral transduction and gene editing in human hematopoietic stem cells. Cell Stem Cell (2018) 23:820–32.e9. doi: 10.1016/j.stem.2018.10.008 PubMed DOI PMC

Jiang L-Q, Xia T, Hu Y-H, Sun M-S, Yan S, Lei C-Q, et al. . IFITM3 inhibits virus-triggered induction of type I interferon by mediating autophagosome-dependent degradation of IRF3. Cell Mol Immunol (2018) 15:858–67. doi: 10.1038/cmi.2017.15 PubMed DOI PMC

McMichael TM, Chemudupati M, Yount JS. A balancing act between IFITM3 and IRF3. Cell Mol Immunol (2018) 15:873–4. doi: 10.1038/cmi.2017.18 PubMed DOI PMC

Schoenherr C, Byron A, Sandilands E, Paliashvili K, Baillie GS, Garcia-Munoz A, et al. . Ambra1 spatially regulates src activity and Src/FAK-mediated cancer cell invasion via trafficking networks. eLife (2017) 6:e23172. doi: 10.7554/eLife.23172 PubMed DOI PMC

Lee J, Goh S-H, Song N, Hwang J-A, Nam S, Choi IJ, et al. . Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism. Am J Pathol (2012) 181:43–52. doi: 10.1016/j.ajpath.2012.03.027 PubMed DOI

Kim NH, Sung HY, Choi EN, Lyu D, Choi HJ, Ju W, et al. . Aberrant DNA methylation in the IFITM1 promoter enhances the metastatic phenotype in an intraperitoneal xenograft model of human ovarian cancer. Oncol Rep (2014) 31:2139–46. doi: 10.3892/or.2014.3110 PubMed DOI

Scott R, Siegrist F, Foser S, Certa U. Interferon-alpha induces reversible DNA demethylation of the interferon-induced transmembrane protein-3 core promoter in human melanoma cells. J Interferon Cytokine Res (2011) 31:601–8. doi: 10.1089/jir.2010.0134 PubMed DOI

Li M, Li Y-P, Deng H-L, Wang M-Q, Chen Y, Zhang Y-F, et al. . DNA Methylation and SNP in IFITM3 are correlated with hand, foot and mouth disease caused by enterovirus 71. Int J Infect Dis (2021) 105:199–208. doi: 10.1016/j.ijid.2021.02.049 PubMed DOI

Kasaai B, Gaumond M-H, Moffatt P. Regulation of the bone-restricted IFITM-like (Bril) gene transcription by sp and gli family members and CpG methylation. J Biol Chem (2013) 288:13278–94. doi: 10.1074/jbc.M113.457010 PubMed DOI PMC

Xiao M, Chen Y, Wang S, Liu S, Rai KR, Chen B, et al. . Long noncoding RNA IFITM4P regulates host antiviral responses by acting as a competing endogenous RNA. J Virol (2021) 95:18. doi: 10.1128/JVI.00277-21 PubMed DOI PMC

Hussein HAM, Akula SM. miRNA-36 inhibits KSHV, EBV, HSV-2 infection of cells via stifling expression of interferon induced transmembrane protein 1 (IFITM1). Sci Rep (2017) 7:17972. doi: 10.1038/s41598-017-18225-w PubMed DOI PMC

Liang Y, Li E, Min J, Gong C, Gao J, Ai J, et al. . miR-29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3. Oncol Rep (2018) 40:3261–72. doi: 10.3892/or.2018.6745 PubMed DOI PMC

Yount JS, Karssemeijer RA, Hang HC. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J Biol Chem (2012) 287:19631–41. doi: 10.1074/jbc.M112.362095 PubMed DOI PMC

Garst EH, Lee H, Das T, Bhattacharya S, Percher A, Wiewiora R, et al. . Site-specific lipidation enhances IFITM3 membrane interactions and antiviral activity. ACS Chem Biol (2021) 16:844–56. doi: 10.1021/acschembio.1c00013 PubMed DOI PMC

Hach JC, McMichael T, Chesarino NM, Yount JS. Palmitoylation on conserved and nonconserved cysteines of murine IFITM1 regulates its stability and anti-influenza a virus activity. J Virol (2013) 87:9923–7. doi: 10.1128/JVI.00621-13 PubMed DOI PMC

Shi Y, Du L, Lv D, Li H, Shang J, Lu J, et al. . Exosomal interferon-induced transmembrane protein 2 transmitted to dendritic cells inhibits interferon alpha pathway activation and blocks anti–hepatitis b virus efficacy of exogenous interferon alpha. Hepatology (2019) 69:2396–413. doi: 10.1002/hep.30548 PubMed DOI PMC

Tsukamoto T, Li X, Morita H, Minowa T, Aizawa T, Hanagata N, et al. . Role of s-palmitoylation on IFITM5 for the interaction with FKBP11 in osteoblast cells. PLoS One (2013) 8:e75831. doi: 10.1371/journal.pone.0075831 PubMed DOI PMC

Chesarino NM, McMichael TM, Yount JS. E3 ubiquitin ligase NEDD4 promotes influenza virus infection by decreasing levels of the antiviral protein IFITM3. PLoS Pathog (2015) 11:e1005095. doi: 10.1371/journal.ppat.1005095 PubMed DOI PMC

Wu X, Spence JS, Das T, Yuan X, Chen C, Zhang Y, et al. . Site-specific photo-crosslinking proteomics reveal regulation of IFITM3 trafficking and turnover by VCP/p97 ATPase. Cell Chem Biol (2020) 27:571–85. doi: 10.1016/j.chembiol.2020.03.004 PubMed DOI PMC

Shan Z, Han Q, Nie J, Cao X, Chen Z, Yin S, et al. . Negative regulation of interferon-induced transmembrane protein 3 by SET7-mediated lysine monomethylation. J Biol Chem (2013) 288:35093–103. doi: 10.1074/jbc.M113.511949 PubMed DOI PMC

Zhao X, Guo F, Liu F, Cuconati A, Chang J, Block TM, et al. . Interferon induction of IFITM proteins promotes infection by human coronavirus OC43. Proc Natl Acad Sci U.S.A. (2014) 111:6756–61. doi: 10.1073/pnas.1320856111 PubMed DOI PMC

Chmielewska AM, Gómez-Herranz M, Gach P, Nekulova M, Bagnucka MA, Lipińska AD, et al. . The role of IFITM proteins in tick-borne encephalitis virus infection. J Virol (2022) 96:e01130–21. doi: 10.1128/JVI.01130-21 PubMed DOI PMC

Winkler M, Wrensch F, Bosch P, Knoth M, Schindler M, Gärtner S, et al. . Analysis of IFITM-IFITM interactions by a flow cytometry-based FRET assay. Int J Mol Sci (2019) 20:3859. doi: 10.3390/ijms20163859 PubMed DOI PMC

Mueller BK, Subramaniam S, Senes A. A frequent, GxxxG-mediated, transmembrane association motif is optimized for the formation of interhelical cα-h hydrogen bonds. Proc Natl Acad Sci USA (2014) 111:E888–895. doi: 10.1073/pnas.1319944111 PubMed DOI PMC

Brem R, Oraszlan-Szovik K, Foser S, Bohrmann B, Certa U. Inhibition of proliferation by 1-8U in interferon-α-responsive and non-responsive cell lines. Cell Mol Life Sci (2003) 60:1235–48. doi: 10.1007/s00018-003-3016-9 PubMed DOI PMC

Deblandre GA, Marinx OP, Evans SS, Majjaj S, Leo O, Caput D, et al. . Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J Biol Chem (1995) 270:23860–6. doi: 10.1074/jbc.270.40.23860 PubMed DOI

Desai TM, Marin M, Chin CR, Savidis G, Brass AL, Melikyan GB. IFITM3 restricts influenza a virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog (2014) 10:e1004048. doi: 10.1371/journal.ppat.1004048 PubMed DOI PMC

Lei N, Li Y, Sun Q, Lu J, Zhou J, Li Z, et al. . IFITM3 affects the level of antibody response after influenza vaccination. Emerg Microbes Infect (2020) 9:976–87. doi: 10.1080/22221751.2020.1756696 PubMed DOI PMC

Tanaka SS, Nagamatsu G, Tokitake Y, Kasa M, Tam PPL, Matsui Y. Regulation of expression of mouse interferon-induced transmembrane protein like gene-3, Ifitm3 (mil-1, fragilis), in germ cells. Dev Dyn (2004) 230:651–9. doi: 10.1002/dvdy.20085 PubMed DOI

Wilkins C, Woodward J, Lau DT -Y., Barnes A, Joyce M, McFarlane N, et al. . IFITM1 is a tight junction protein that inhibits hepatitis c virus entry. Hepatology (2013) 57:461–9. doi: 10.1002/hep.26066 PubMed DOI PMC

Yang G, Xu Y, Chen X, Hu G. IFITM1 plays an essential role in the antiproliferative action of interferon-c. Oncogene (2007) 26:594–603. doi: 10.1038/sj.onc.1209807 PubMed DOI

Zani A, Zhang L, McMichael TM, Kenney AD, Chemudupati M, Kwiek JJ, et al. . Interferon-induced transmembrane proteins inhibit cell fusion mediated by trophoblast syncytins. J Biol Chem (2019) 294:19844–51. doi: 10.1074/jbc.AC119.010611 PubMed DOI PMC

Cho T-J, Lee K-E, Lee S-K, Song SJ, Kim KJ, Jeon D, et al. . A single recurrent mutation in the 5’-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet (2012) 91:343–8. doi: 10.1016/j.ajhg.2012.06.005 PubMed DOI PMC

Hur J-Y, Frost GR, Wu X, Crump C, Pan SJ, Wong E, et al. . The innate immunity protein IFITM3 modulates γ-secretase in alzheimer’s disease. Nature (2020) 586:735–40. doi: 10.1038/s41586-020-2681-2 PubMed DOI PMC

Alber D. Staeheli p. partial inhibition of vesicular stomatitis virus by the interferon-induced human 9-27 protein. J Interferon Cytokine Res (1996) 16:375–80. doi: 10.1089/jir.1996.16.375 PubMed DOI

Brass AL, Huang I-C, Benita Y, John SP, Krishnan MN, Feeley EM, et al. . The IFITM proteins mediate cellular resistance to influenza a H1N1 virus, West Nile virus, and dengue virus. Cell (2009) 139:1243–54. doi: 10.1016/j.cell.2009.12.017 PubMed DOI PMC

Anafu AA, Bowen CH, Chin CR, Brass AL, Holm GH. Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. J Biol Chem (2013) 288:17261–71. doi: 10.1074/jbc.M112.438515 PubMed DOI PMC

Warren CJ, Griffin LM, Little AS, Huang I-C, Farzan M, Pyeon D. The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus. PLoS One (2014) 9:e96579. doi: 10.1371/journal.pone.0096579 PubMed DOI PMC

Weidner JM, Jiang D, Pan X-B, Chang J, Block TM, Guo J-T. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol (2010) 84:12646–57. doi: 10.1128/JVI.01328-10 PubMed DOI PMC

Liao Y, Goraya MU, Yuan X, Zhang B, Chiu S-H, Chen J-L. Functional involvement of interferon-inducible transmembrane proteins in antiviral immunity. Front Microbiol (2019) 10:1097. doi: 10.3389/fmicb.2019.01097 PubMed DOI PMC

Marziali F, Cimarelli A. Membrane interference against HIV-1 by intrinsic antiviral factors: The case of IFITMs. Cells (2021) 10:1171. doi: 10.3390/cells10051171 PubMed DOI PMC

Ren L, Du S, Xu W, Li T, Wu S, Jin N, et al. . Current progress on host antiviral factor IFITMs. Front Immunol (2020) 11:543444. doi: 10.3389/fimmu.2020.543444 PubMed DOI PMC

Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang I-C, Farzan M, et al. . The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe (2013) 13:452–64. doi: 10.1016/j.chom.2013.03.006 PubMed DOI PMC

Rahman K, Datta SAK, Beaven AH, Jolley AA, Sodt AJ, Compton AA. Cholesterol binds the amphipathic helix of IFITM3 and regulates antiviral activity. J Mol Biol (2022) 434:167759. doi: 10.1016/j.jmb.2022.167759 PubMed DOI PMC

Spence JS, He R, Hoffmann H-H, Das T, Thinon E, Rice CM, et al. . IFITM3 directly engages and shuttles incoming virus particles to lysosomes. Nat Chem Biol (2019) 15:259–68. doi: 10.1038/s41589-018-0213-2 PubMed DOI PMC

Gerlach T, Hensen L, Matrosovich T, Bergmann J, Winkler M, Peteranderl C, et al. . pH optimum of hemagglutinin-mediated membrane fusion determines sensitivity of influenza a viruses to the interferon-induced antiviral state and IFITMs. J Virol (2017) 91:e00246-17. doi: 10.1128/JVI.00246-17 PubMed DOI PMC

Wee YS, Roundy KM, Weis JJ, Weis JH. Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function. Innate Immun (2012) 18:834–45. doi: 10.1177/1753425912443392 PubMed DOI

Huang I-C, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, et al. . Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza a virus. PLoS Pathog (2011) 7:e1001258. doi: 10.1371/journal.ppat.1001258 PubMed DOI PMC

Wrensch F, Winkler M, Pöhlmann S. IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms. Viruses (2014) 6:3683–98. doi: 10.3390/v6093683 PubMed DOI PMC

Prelli Bozzo C, Nchioua R, Volcic M, Koepke L, Krüger J, Schütz D, et al. . IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition. vitro Nat Commun (2021) 12:4584. doi: 10.1038/s41467-021-24817-y PubMed DOI PMC

Nchioua R, Schundner A, Kmiec D, Prelli Bozzo C, Zech F, Koepke L, et al. . SARS-CoV-2 variants of concern hijack IFITM2 for efficient replication in human lung cells. J Virol (2022) 96:e00594-22. doi: 10.1128/jvi.00594-22 PubMed DOI PMC

Zang R, Case JB, Yutuc E, Ma X, Shen S, Gomez Castro MF, et al. . Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion. Proc Natl Acad Sci (2020) 117:32105–13. doi: 10.1073/pnas.2012197117 PubMed DOI PMC

Shi G, Kenney AD, Kudryashova E, Zani A, Zhang L, Lai KK, et al. . Opposing activities of IFITM proteins in SARS-CoV-2 infection. EMBO J (2021) 40:e106501. doi: 10.15252/embj.2020106501 PubMed DOI PMC

Winstone H, Lista MJ, Reid AC, Bouton C, Pickering S, Galao RP, et al. . The polybasic cleavage site in SARS-CoV-2 spike modulates viral sensitivity to type I interferon and IFITM2. J Virol (2021) 95:e02422-20. doi: 10.1128/JVI.02422-20 PubMed DOI PMC

Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, et al. . Syncytia formation by SARS-CoV-2-infected cells. EMBO J (2021) 40:e107405. doi: 10.15252/embj.2020107405 PubMed DOI PMC

Duncan R, Chen Z, Walsh S, Wu S. Avian reovirus-induced syncytium formation is independent of infectious progeny virus production and enhances the rate, but is not essential, for virus-induced cytopathology and virus egress. Virology (1996) 224:453–64. doi: 10.1006/viro.1996.0552 PubMed DOI

Watkins BA, Crowley R, Davis AE, Louie AT, Reitz MS. Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4. J Gen Virol (1997) 78:2513–22. doi: 10.1099/0022-1317-78-10-2513 PubMed DOI

Horvath CM, Paterson RG, Shaughnessy MA, Wood R, Lamb RA. Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol (1992) 66:4564–9. doi: 10.1128/JVI.66.7.4564-4569.1992 PubMed DOI PMC

Ambrosini AE, Enquist LW. Cell-fusion events induced by α-herpesviruses. Future Virol (2015) 10:185–200. doi: 10.2217/fvl.14.100 DOI

Lin L, Li Q, Wang Y, Shi Y. Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes. Cell Death Differ (2021) 28:2019–21. doi: 10.1038/s41418-021-00795-y PubMed DOI PMC

White JM, Delos SE, Brecher M, Schornberg K. Structures and mechanisms of viral membrane fusion proteins. Crit Rev Biochem Mol Biol (2008) 43:189–219. doi: 10.1080/10409230802058320 PubMed DOI PMC

Buchrieser J, Degrelle SA, Couderc T, Nevers Q, Disson O, Manet C, et al. . IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise. Science (2019) 365:176–80. doi: 10.1126/science.aaw7733 PubMed DOI

Weir ML, Xie H, Klip A, Trimble WS. VAP-a binds promiscuously to both v- and tSNAREs. Biochem Biophys Res Commun (2001) 286:616–21. doi: 10.1006/bbrc.2001.5437 PubMed DOI

Kentala H, Pfisterer SG, Olkkonen VM, Weber-Boyvat M. Sterol liganding of OSBP-related proteins (ORPs) regulates the subcellular distribution of ORP-VAPA complexes and their impacts on organelle structure. Steroids (2015) 99:248–58. doi: 10.1016/j.steroids.2015.01.027 PubMed DOI

Liu W, Chakraborty B, Safi R, Kazmin D, Chang C, McDonnell DP. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun (2021) 12:5103. doi: 10.1038/s41467-021-25354-4 PubMed DOI PMC

Pfrieger FW. Neurodegenerative diseases and cholesterol: Seeing the field through the players. Front Aging Neurosci (2021) 13:766587. doi: 10.3389/fnagi.2021.766587 PubMed DOI PMC

Reboldi A, Dang E. Cholesterol metabolism in innate and adaptive response. F1000Research (2018) 7:F1000. doi: 10.12688/f1000research.15500.1 PubMed DOI PMC

Zhong L, Song Y, Marziali F, Uzbekov R, Nguyen X-N, Journo C, et al. . A novel domain within the CIL regulates egress of IFITM3 from the golgi and reveals a regulatory role of IFITM3 on the secretory pathway. Life Sci Alliance (2022) 5:e202101174. doi: 10.26508/lsa.202101174 PubMed DOI PMC

Guo X, Steinkühler J, Marin M, Li X, Lu W, Dimova R, et al. . Interferon-induced transmembrane protein 3 blocks fusion of diverse enveloped viruses by altering mechanical properties of cell membranes. ACS Nano (2021) 15:8155–70. doi: 10.1021/acsnano.0c10567 PubMed DOI PMC

Das T, Yang X, Lee H, Garst EH, Valencia E, Chandran K, et al. . S-palmitoylation and sterol interactions mediate antiviral specificity of IFITMs. ACS Chem Biol (2022) 17:2109–20. doi: 10.1021/acschembio.2c00176 PubMed DOI PMC

Smrt ST, Draney AW, Lorieau JL. The influenza hemagglutinin fusion domain is an amphipathic helical hairpin that functions by inducing membrane curvature *. J Biol Chem (2015) 290:228–38. doi: 10.1074/jbc.M114.611657 PubMed DOI PMC

Churchward MA, Rogasevskaia T, Höfgen J, Bau J, Coorssen JR. Cholesterol facilitates the native mechanism of Ca2+-triggered membrane fusion. J Cell Sci (2005) 118:4833–48. doi: 10.1242/jcs.02601 PubMed DOI

Yu J, Li M, Wilkins J, Ding S, Swartz TH, Esposito AM, et al. . IFITM proteins restrict HIV-1 infection by antagonizing the envelope glycoprotein. Cell Rep (2015) 13:145–56. doi: 10.1016/j.celrep.2015.08.055 PubMed DOI PMC

Cheong SC, Chandramouli GVR, Saleh A, Zain RB, Lau SH, Sivakumaren S, et al. . Gene expression in human oral squamous cell carcinoma is influenced by risk factor exposure. Oral Oncol (2009) 45:712–9. doi: 10.1016/j.oraloncology.2008.11.002 PubMed DOI

Choi S, Jang JH, Kim KR. Analysis of differentially expressed genes in human rectal carcinoma using suppression subtractive hybridization. Clin Exp Med (2011) 11:219–26. doi: 10.1007/s10238-010-0130-5 PubMed DOI

Daniel-Carmi V, Makovitzki-Avraham E, Reuven E-M, Goldstein I, Zilkha N, Rotter V, et al. . The human 1-8D gene ( IFITM2 ) is a novel p53 independent pro-apoptotic gene. Int J Cancer (2009) 125:2810–9. doi: 10.1002/ijc.24669 PubMed DOI

Gan CP, Sam KK, Yee PS, Zainal NS, Lee BKB, Abdul Rahman ZA, et al. . IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells. Cell Oncol Dordr (2019) 42:477–90. doi: 10.1007/s13402-019-00437-z PubMed DOI PMC

He J, Luo H, Li J, Feng W, Chen L. Influences of the interferon induced transmembrane protein 1 on the proliferation, invasion, and metastasis of the colorectal cancer SW480 cell lines. Chin Med J (Engl) (2012) 125:517–22. doi: 10.3760/cma.j.issn.0366-6999.2012.03.021 PubMed DOI

Hu J, Wang S, Zhao Y, Guo Q, Zhang D, Chen J, et al. . Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer. Oncol Rep (2014) 32:2648–56. doi: 10.3892/or.2014.3522 PubMed DOI

Tirosh B, Daniel-Carmi V, Carmon L, Paz A, Lugassy G, Vadai E, et al. . ‘1-8 interferon inducible gene family’: putative colon carcinoma-associated antigens. Br J Cancer (2007) 97:1655–63. doi: 10.1038/sj.bjc.6604061 PubMed DOI PMC

Yang Y, Lee J-H, Yong Kim K, Keun Song H, Kwang Kim J, Ran Yoon S, et al. . The interferon-inducible 9-27 gene modulates the susceptibility to natural killer cells and the invasiveness of gastric cancer cells. Cancer Lett (2005) 221:191–200. doi: 10.1016/j.canlet.2004.08.022 PubMed DOI

Provance OK, Geanes ES, Lui AJ, Roy A, Holloran SM, Gunewardena S, et al. . Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression. Cancer Lett (2021) 514:12–29. doi: 10.1016/j.canlet.2021.05.006 PubMed DOI PMC

Wang Y, Peng H, Zhong Y, Li D, Tang M, Ding X, et al. . Differential gene expression profiling of human epidermal growth factor receptor 2-overexpressing mammary tumor. Acta Biochim Biophys Sin (2008) 40:397–405. doi: 10.1111/j.1745-7270.2008.00419.x PubMed DOI

Yang M, Gao H, Chen P, Jia J, Wu S. Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle. Oncol Rep (2013) 30:171–8. doi: 10.3892/or.2013.2428 PubMed DOI

Zhang D, Wang H, He H, Niu H, Li Y. Interferon induced transmembrane protein 3 regulates the growth and invasion of human lung adenocarcinoma: IFITM3 and lung adenocarcinoma. Thorac Cancer (2017) 8:337–43. doi: 10.1111/1759-7714.12451 PubMed DOI PMC

Hou Y, Wang S, Gao M, Chang J, Sun J, Qin L, et al. . Interferon-induced transmembrane protein 3 expression upregulation is involved in progression of hepatocellular carcinoma. BioMed Res Int (2021) 2021:e5612138. doi: 10.1155/2021/5612138 PubMed DOI PMC

Seyfried NT, Huysentruyt LC, Atwood JA, Xia Q, Seyfried TN, Orlando R. Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach. Cancer Lett (2008) 263:243–52. doi: 10.1016/j.canlet.2008.01.007 PubMed DOI PMC

Zhao B, Wang H, Zong G, Li P. The role of IFITM3 in the growth and migration of human glioma cells. BMC Neurol (2013) 13:210. doi: 10.1186/1471-2377-13-210 PubMed DOI PMC

Liu Y, Lu R, Cui W, Pang Y, Liu C, Cui L, et al. . High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia. Cancer Gene Ther (2020) 27:38–44. doi: 10.1038/s41417-019-0093-y PubMed DOI

He J, Li J, Feng W, Chen L, Yang K. Prognostic significance of INF-induced transmembrane protein 1 in colorectal cancer. Int J Clin Exp Pathol (2015) 8:16007–13. PubMed PMC

Sari NI, Yang Y-G, Phi LTH, Kim H, Baek MJ, Jeong D, et al. . Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer. Oncotarget (2016) 7:86039–50. doi: 10.18632/oncotarget.13325 PubMed DOI PMC

Lui AJ, Geanes ES, Ogony J, Behbod F, Marquess J, Valdez K, et al. . IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21. Cancer Lett (2017) 399:29–43. doi: 10.1016/j.canlet.2017.04.005 PubMed DOI PMC

Xu L, Zhou R, Yuan L, Wang S, Li X, Ma H, et al. . IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis. Cancer Lett (2017) 393:76–85. doi: 10.1016/j.canlet.2017.02.014 PubMed DOI

Yang N, Liu Z, Pang S, Wu J, Liang J, Sun L. Predicative value of IFITM2 in renal clear cell carcinoma: IFITM2 is associated with lymphatic metastasis and poor clinical outcome. Biochem Biophys Res Commun (2021) 534:157–64. doi: 10.1016/j.bbrc.2020.11.124 PubMed DOI

Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF. The CD19/CD21 signal transducing complex of human b lymphocytes includes the target of antiproliferative antibody-1 and leu-13 molecules. J Immunol (1992) 149:2841–50. PubMed

Levine AJ. p53: 800 million years of evolution and 40 years of discovery. Nat Rev Cancer (2020) 20:471–80. doi: 10.1038/s41568-020-0262-1 PubMed DOI

Lau SL, Yuen M, Kou CY, Au K, Zhou J, Tsui SK. Interferons induce the expression of IFITM1 and IFITM3 and suppress the proliferation of rat neonatal cardiomyocytes. J Cell Biochem (2012) 113:841–7. doi: 10.1002/jcb.23412 PubMed DOI PMC

El-Tanani MK, Jin D, Campbell FC, Johnston PG. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression. Oncogene (2010) 29:752–62. doi: 10.1038/onc.2009.379 PubMed DOI

Del Prete A, Scutera S, Sozzani S, Musso T. Role of osteopontin in dendritic cell shaping of immune responses. Cytokine Growth Factor Rev (2019) 50:19–28. doi: 10.1016/j.cytogfr.2019.05.004 PubMed DOI

Kahles F, Findeisen HM, Bruemmer D. Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes. Mol Metab (2014) 3:384–93. doi: 10.1016/j.molmet.2014.03.004 PubMed DOI PMC

Standal T, Borset M, Sundan A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol (2004) 26:179–84. PubMed

Klement JD, Paschall AV, Redd PS, Ibrahim ML, Lu C, Yang D, et al. . An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest (2018) 128:5549–60. doi: 10.1172/JCI123360 PubMed DOI PMC

Rosati A, Basile A, D’Auria R, d’Avenia M, De Marco M, Falco A, et al. . BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages. Nat Commun (2015) 6:8695. doi: 10.1038/ncomms9695 PubMed DOI PMC

Cui K, Wang H, Zai S, Feng Y. Expression of IFITM3 in colorectal carcinoma and its clinical significance. Chin J Oncol (2015) 37:352–5. PubMed

Cui Y, Zhu T, Song X, Liu J, Liu S, Zhao R. Downregulation of caveolin-1 increased EGFR-TKIs sensitivity in lung adenocarcinoma cell line with EGFR mutation. Biochem Biophys Res Commun (2018) 495:733–9. doi: 10.1016/j.bbrc.2017.11.075 PubMed DOI

Sakamoto S, Inoue H, Kohda Y, Ohba S, Mizutani T, Kawada M. Interferon-induced transmembrane protein 1 (IFITM1) promotes distant metastasis of small cell lung cancer. Int J Mol Sci (2020) 21:4934. doi: 10.3390/ijms21144934 PubMed DOI PMC

Sigismund S, Avanzato D, Lanzetti L. Emerging functions of the EGFR in cancer. Mol Oncol (2018) 12:3–20. doi: 10.1002/1878-0261.12155 PubMed DOI PMC

Janković J, Tatić S, Božić V, Živaljević V, Cvejić D, Paskaš S. Inverse expression of caveolin-1 and EGFR in thyroid cancer patients. Hum Pathol (2017) 61:164–72. doi: 10.1016/j.humpath.2016.10.020 PubMed DOI

Yang Y-G, Koh YW, Sari IN, Jun N, Lee S, Phi LTH, et al. . Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer. Int J Cancer (2019) 144:2020–32. doi: 10.1002/ijc.31926 PubMed DOI PMC

Yu F, Xie D, Ng SS, Lum CT, Cai M-Y, Cheung WK, et al. . IFITM1 promotes the metastasis of human colorectal cancer via CAV-1. Cancer Lett (2015) 368:135–43. doi: 10.1016/j.canlet.2015.07.034 PubMed DOI

Mizoshiri N, Shirai T, Terauchi R, Tsuchida S, Mori Y, Hayashi D, et al. . The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma. Cell Oncol (2019) 42:861–71. doi: 10.1007/s13402-019-00472-w PubMed DOI

Vences-Catalán F, Rajapaksa R, Srivastava MK, Marabelle A, Kuo C-C, Levy R, et al. . Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells. Cancer Res (2015) 75:4517–26. doi: 10.1158/0008-5472.CAN-15-1021 PubMed DOI

Zhang Y, Qian H, Xu A, Yang G. Increased expression of CD81 is associated with poor prognosis of prostate cancer and increases the progression of prostate cancer cells. vitro Exp Ther Med (2020) 19:755–61. doi: 10.3892/etm.2019.8244 PubMed DOI PMC

Hatano H, Kudo Y, Ogawa I, Tsunematsu T, Kikuchi A, Abiko Y, et al. . IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression. Clin Cancer Res (2008) 14:6097–105. doi: 10.1158/1078-0432.CCR-07-4761 PubMed DOI

Ma Y, Zhang G, Fu X, Xia O, Zhan C, Li L, et al. . Wnt signaling may be activated in a subset of peutz-jeghers syndrome polyps closely correlating to LKB1 expression. Oncol Rep (2010) 23:1569–76. doi: 10.3892/or_00000797 PubMed DOI

Zhang L, Wang Z, Kong D, Zhao X, Chen X, Chai W. Knockdown of interferon-induced transmembrane protein 1 inhibited proliferation, induced cell cycle arrest and apoptosis, and suppressed MAPK signaling pathway in pancreatic cancer cells. Biosci Biotechnol Biochem (2020) 84:1603–13. doi: 10.1080/09168451.2020.1762479 PubMed DOI

Elyada E, Pribluda A, Goldstein RE, Morgenstern Y, Brachya G, Cojocaru G, et al. . CKIα ablation highlights a critical role for p53 in invasiveness control. Nature (2011) 470:409–13. doi: 10.1038/nature09673 PubMed DOI

Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, et al. . Axin-mediated CKI phosphorylation of beta-catenin at ser 45: a molecular switch for the wnt pathway. Genes Dev (2002) 16:1066–76. doi: 10.1101/gad.230302 PubMed DOI PMC

Koh YW, Han J-H, Jeong D, Kim C-J. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial–mesenchymal transition signature in lung adenocarcinoma. Pathol - Res Pract (2019) 215:152444. doi: 10.1016/j.prp.2019.152444 PubMed DOI

Kim BS, Yang S-S, Kim C-S, Lee J. Zoledronate suppresses VEGF−induced capillary tube formation and inhibits expression of interferon−induced transmembrane protein−1 in human umbilical vein endothelial cells. Int J Mol Med (2018) 41:2879–84. doi: 10.3892/ijmm.2018.3497 PubMed DOI

Fumoto S, Shimokuni T, Tanimoto K, Hiyama K, Otani K, Ohtaki M, et al. . Selection of a novel drug-response predictor in esophageal cancer: A novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response. Int J Oncol (2008) 32:413–23. doi: 10.3892/ijo.32.2.413 PubMed DOI

Khodarev NN, Beckett M, Labay E, Darga T, Roizman B, Weichselbaum RR. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci U.S.A. (2004) 101:1714–9. doi: 10.1073/pnas.0308102100 PubMed DOI PMC

Yang J, Li L, Xi Y, Sun R, Wang H, Ren Y, et al. . Combination of IFITM1 knockdown and radiotherapy inhibits the growth of oral cancer. Cancer Sci (2018) 109:3115–28. doi: 10.1111/cas.13640 PubMed DOI PMC

Goad DW, Bressy C, Holbrook MC, Grdzelishvili VZ. Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus. Mol Ther - Oncolytics (2022) 24:59–76. doi: 10.1016/j.omto.2021.11.019 PubMed DOI PMC

Erdal E, Haider S, Rehwinkel J, Harris AL, McHugh PJ. A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1. Genes Dev (2017) 31:353–69. doi: 10.1101/gad.289769.116 PubMed DOI PMC

Yu Q, Katlinskaya YV, Carbone CJ, Zhao B, Katlinski KV, Zheng H, et al. . DNA-Damage-Induced type I interferon promotes senescence and inhibits stem cell function. Cell Rep (2015) 11:785–97. doi: 10.1016/j.celrep.2015.03.069 PubMed DOI PMC

Cheon H, Stark GR. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc Natl Acad Sci U.S.A. (2009) 106:9373–8. doi: 10.1073/pnas.0903487106 PubMed DOI PMC

Cheon H, Holvey-Bates EG, Schoggins JW, Forster S, Hertzog P, Imanaka N, et al. . IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage. EMBO J (2013) 32:2751–63. doi: 10.1038/emboj.2013.203 PubMed DOI PMC

Cheon H, Yang J, Stark GR. The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins. J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res (2011) 31:33–40. doi: 10.1089/jir.2010.0100 PubMed DOI PMC

Gongora C, Candeil L, Vezzio N, Copois V, Denis V, Breil C, et al. . Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38. Cancer Biol Ther (2008) 7:822–32. doi: 10.4161/cbt.7.6.5838 PubMed DOI

Luszczek W, Cheriyath V, Mekhail TM, Borden EC. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: Correlation of resistance with IFN-stimulated gene expression. Mol Cancer Ther (2010) 9:2309–21. doi: 10.1158/1535-7163.MCT-10-0309 PubMed DOI

Yamashita N, Fushimi A, Morimoto Y, Bhattacharya A, Hagiwara M, Yamamoto M, et al. . Targeting MUC1-c suppresses chronic activation of cytosolic nucleotide receptors and STING in triple-negative breast cancer. Cancers (2022) 14:2580. doi: 10.3390/cancers14112580 PubMed DOI PMC

Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. Cytoplasmic localization of p21Cip1/WAF1 by akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol (2001) 3:245–52. doi: 10.1038/35060032 PubMed DOI

Koster R, di Pietro A, Timmer-Bosscha H, Gibcus JH, van den Berg A, Suurmeijer AJ, et al. . Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. J Clin Invest (2010) 120:3594–605. doi: 10.1172/JCI41939 PubMed DOI PMC

Xia X, Ma Q, Li X, Ji T, Chen P, Xu H, et al. . Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer. BMC Cancer (2011) 11:399. doi: 10.1186/1471-2407-11-399 PubMed DOI PMC

Pan GJ, Chang ZY, Schöler HR, Pei D. Stem cell pluripotency and transcription factor Oct4. Cell Res (2002) 12:321–9. doi: 10.1038/sj.cr.7290134 PubMed DOI

Zhang J, Chen D, Liang S, Wang J, Liu C, Nie C, et al. . miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC. Oncol Lett (2018) 15:4619–26. doi: 10.3892/ol.2018.7861 PubMed DOI PMC

Le TVT, Seo Y, Ryu CJ, Lee HR, Park H-J. Increased expression of p27 is associated with the cisplatin resistance in gastric cancer cell line YCC-3. Arch Pharm Res (2010) 33:1127–32. doi: 10.1007/s12272-010-0720-5 PubMed DOI

Lee HR, No HK, Ryu CJ, Park H-J. Brahma−related gene 1-associated expression of 9-27 and IFI-27 is involved in acquired cisplatin resistance of gastric cancer cells. Mol Med Rep (2013) 8:747–50. doi: 10.3892/mmr.2013.1576 PubMed DOI

Choi HJ, Lui A, Ogony J, Jan R, Sims PJ, Lewis-Wambi J. Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death. Breast Cancer Res (2015) 17:6. doi: 10.1186/s13058-014-0506-7 PubMed DOI PMC

Tanaka SS, Yamaguchi YL, Tsoi B, Lickert H, Tam PPL. IFITM/Mil/Fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. Dev Cell (2005) 9:745–56. doi: 10.1016/j.devcel.2005.10.010 PubMed DOI

Lange UC, Adams DJ, Lee C, Barton S, Schneider R, Bradley A, et al. . Normal germ line establishment in mice carrying a deletion of the Ifitm/Fragilis gene family cluster. Mol Cell Biol (2008) 28:4688–96. doi: 10.1128/MCB.00272-08 PubMed DOI PMC

Fu Y, Zhou Z, Wang H, Gong P, Guo R, Wang J, et al. . IFITM1 suppresses expression of human endogenous retroviruses in human embryonic stem cells. FEBS Open Bio (2017) 7:1102–10. doi: 10.1002/2211-5463.12246 PubMed DOI PMC

Grow EJ, Flynn RA, Chavez SL, Bayless NL, Wossidlo M, Wesche D, et al. . Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells. Nature (2015) 522:221–5. doi: 10.1038/nature14308 PubMed DOI PMC

Wu L, Tang Q, Yin X, Yan D, Tang M, Xin J, et al. . The therapeutic potential of adipose tissue-derived mesenchymal stem cells to enhance radiotherapy effects on hepatocellular carcinoma. Front Cell Dev Biol (2019) 7:267. doi: 10.3389/fcell.2019.00267 PubMed DOI PMC

Bezman NA, Kim CC, Sun JC, Min-Oo G, Hendricks DW, Kamimura Y, et al. . Molecular definition of the identity and activation of natural killer cells. Nat Immunol (2012) 13:1000–9. doi: 10.1038/ni.2395 PubMed DOI PMC

Ranjbar S, Haridas V, Jasenosky LD, Falvo JV, Goldfeld AE. A role for IFITM proteins in restriction of mycobacterium tuberculosis infection. Cell Rep (2015) 13:874–83. doi: 10.1016/j.celrep.2015.09.048 PubMed DOI PMC

Campbell RA, Schwertz H, Hottz ED, Rowley JW, Manne BK, Washington AV, et al. . Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3. Blood (2019) 133:2013–26. doi: 10.1182/blood-2018-09-873984 PubMed DOI PMC

Chen YX, Welte K, Gebhard DH, Evans RL. Induction of T cell aggregation by antibody to a 16kd human leukocyte surface antigen. J Immunol (1984) 133:2496–501. PubMed

Levy S, Todd SC, Maecker HT. CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol (1998) 16:89–109. doi: 10.1146/annurev.immunol.16.1.89 PubMed DOI

Matsumoto AK, Martin DR, Carter RH, Klickstein LB, Ahearn JM, Fearon DT. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of b lymphocytes. J Exp Med (1993) 178:1407–17. doi: 10.1084/jem.178.4.1407 PubMed DOI PMC

Hanna J, Bechtel P, Zhai Y, Youssef F, McLachlan K, Mandelboim O. Novel insights on human NK cells’ immunological modalities revealed by gene expression profiling. J Immunol (2004) 173:6547–63. doi: 10.4049/jimmunol.173.11.6547 PubMed DOI

Infusini G, Smith JM, Yuan H, Pizzolla A, Ng WC, Londrigan SL, et al. . Respiratory DC use IFITM3 to avoid direct viral infection and safeguard virus-specific CD8+ T cell priming. PLoS One (2015) 10:e0143539. doi: 10.1371/journal.pone.0143539 PubMed DOI PMC

Wrensch F, Karsten CB, Gnirß K, Hoffmann M, Lu K, Takada A, et al. . Interferon-induced transmembrane protein-mediated inhibition of host cell entry of ebolaviruses. J Infect Dis (2015) 212 Suppl 2:S210–218. doi: 10.1093/infdis/jiv255 PubMed DOI PMC

Levine S, Xian CY, Agocha B, Allopenna J, Welte K, Armstrong D, et al. . Differential modulation of the CD-2 and CD-3 T cell activation pathways by a monoclonal antibody to leu-13. Cell Immunol (1991) 132:366–76. doi: 10.1016/0008-8749(91)90034-9 PubMed DOI

Alteber Z, Sharbi-Yunger A, Pevsner-Fischer M, Blat D, Roitman L, Tzehoval E, et al. . The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota. Immunol Cell Biol (2018) 96:284–97. doi: 10.1111/imcb.12000 PubMed DOI

Evans SS, Lee DB, Han T, Tomasi TB, Evans RL. Monoclonal antibody to the interferon-inducible protein leu-13 triggers aggregation and inhibits proliferation of leukemic b cells. Blood (1990) 76:2583–93. PubMed

Frey M, Appenheimer MM, Evans SS. Tyrosine kinase-dependent regulation of l-selectin expression through the leu-13 signal transduction molecule: evidence for a protein kinase c-independent mechanism of l-selectin shedding. J Immunol (1997) 158:5424–34. PubMed

Amet T, Son YM, Jiang L, Cheon IS, Huang S, Gupta SK, et al. . BCL6 represses antiviral resistance in follicular T helper cells. J Leukoc Biol (2017) 102:527–36. doi: 10.1189/jlb.4A1216-513RR PubMed DOI PMC

Sun Q, Lei N, Lu J, Gao RB, Li Z, Liu LQ, et al. . Interferon-induced transmembrane protein 3 prevents acute influenza pathogenesis in mice. BioMed Environ Sci (2020) 33:295–305. doi: 10.3967/bes2020.041 PubMed DOI

Stacey MA, Clare S, Clement M, Marsden M, Abdul-Karim J, Kane L, et al. . The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis. J Clin Invest (2017) 127:1463–74. doi: 10.1172/JCI84889 PubMed DOI PMC

Clement M, Forbester JL, Marsden M, Sabberwal P, Sommerville MS, Wellington D, et al. . IFITM3 restricts virus-induced inflammatory cytokine production by limiting nogo-b mediated TLR responses. Nat Commun (2022) 13:5294. doi: 10.1038/s41467-022-32587-4 PubMed DOI PMC

Song M, Ping Y, Zhang K, Yang L, Li F, Zhang C, et al. . Low-dose IFNγ induces tumor cell stemness in tumor microenvironment of non–small cell lung cancer. Cancer Res (2019) 79:3737–48. doi: 10.1158/0008-5472.CAN-19-0596 PubMed DOI

Thibaut R, Bost P, Milo I, Cazaux M, Lemaître F, Garcia Z, et al. . Bystander IFN-γ activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment. Nat Cancer (2020) 1:302–14. doi: 10.1038/s43018-020-0038-2 PubMed DOI PMC

Cai Y, Ji W, Sun C, Xu R, Chen X, Deng Y, et al. . Interferon-induced transmembrane protein 3 shapes an inflamed tumor microenvironment and identifies immuno-hot tumors. Front Immunol (2021) 12:704965. doi: 10.3389/fimmu.2021.704965 PubMed DOI PMC

Shen C, Li Y-J, Yin Q-Q, Jiao W-W, Li Q-J, Xiao J, et al. . Identification of differentially expressed transcripts targeted by the knockdown of endogenous IFITM3. Mol Med Rep (2016) 14:4367–73. doi: 10.3892/mmr.2016.5777 PubMed DOI

Zhang R, Liu Q, Li T, Liao Q, Zhao Y. Role of the complement system in the tumor microenvironment. Cancer Cell Int (2019) 19:300. doi: 10.1186/s12935-019-1027-3 PubMed DOI PMC

Gómez-Herranz M, Nekulova M, Faktor J, Hernychova L, Kote S, Sinclair EH, et al. . The effects of IFITM1 and IFITM3 gene deletion on IFNγ stimulated protein synthesis. Cell Signal (2019) 60:39–56. doi: 10.1016/j.cellsig.2019.03.024 PubMed DOI PMC

Wu L, Zhu X, Yan D, Tang M, Ma C, Yan S. Identification of IFN-induced transmembrane protein 1 with prognostic value in pancreatic cancer using network module-based analysis. Front Oncol (2021) 0:626883. doi: 10.3389/fonc.2021.626883 PubMed DOI PMC

Xu Y, Huang D, Zhang K, Tang Z, Ma J, Zhu M, et al. . Overexpressing IFITM family genes predict poor prognosis in kidney renal clear cell carcinoma. Transl Androl Urol (2021) 10:3837–51. doi: 10.21037/tau-21-848 PubMed DOI PMC

Li H, Yang L-L, Wu C-C, Xiao Y, Mao L, Chen L, et al. . Expression and prognostic value of IFIT1 and IFITM3 in head and neck squamous cell carcinoma. Am J Clin Pathol (2020) 153:618–29. doi: 10.1093/ajcp/aqz205 PubMed DOI

Alshetaiwi H, Pervolarakis N, McIntyre LL, Ma D, Nguyen Q, Rath JA, et al. . Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics. Sci Immunol (2020) 5:eaay6017. doi: 10.1126/sciimmunol.aay6017 PubMed DOI PMC

Yi J, Wang Y, Zhang H, Deng X, Xi J, Li H, et al. . Interferon-inducible transmembrane protein 3-containing exosome as a new carrier for the cell-to-Cell transmission of anti-brucella activity. Front Vet Sci (2021) 8:642968. doi: 10.3389/fvets.2021.642968 PubMed DOI PMC

Zhu X, He Z, Yuan J, Wen W, Huang X, Hu Y, et al. . IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection. Cell Microbiol (2015) 17:105–18. doi: 10.1111/cmi.12339 PubMed DOI PMC

Li J, Liu K, Liu Y, Xu Y, Zhang F, Yang H, et al. . Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity. Nat Immunol (2013) 14:793–803. doi: 10.1038/ni.2647 PubMed DOI

Kelemen A, Carmi I, Oszvald Á, Lőrincz P, Petővári G, Tölgyes T, et al. . IFITM1 expression determines extracellular vesicle uptake in colorectal cancer. Cell Mol Life Sci CMLS (2021) 78:7009–24. doi: 10.1007/s00018-021-03949-w PubMed DOI PMC

IFITM1 as a modulator of surfaceome dynamics and aggressive phenotype in cervical cancer cells

Biochemical evidence for conformational variants in the anti-viral and pro-metastatic protein IFITM1